CRISPR Therapeutics AG (CRSP)

53.29 -2.36 (-4.24%) USD  |  NASDAQ  |  Apr 25, 10:03
More

CRISPR Therapeutics Total Assets (Quarterly): 2.230B for Dec. 31, 2023

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2015. Upgrade now.
Date Value
December 31, 2023 2.230B
September 30, 2023 2.087B
June 30, 2023 2.197B
March 31, 2023 2.244B
December 31, 2022 2.243B
September 30, 2022 2.353B
June 30, 2022 2.463B
March 31, 2022 2.606B
December 31, 2021 2.752B
September 30, 2021 2.822B
June 30, 2021 2.900B
March 31, 2021 1.958B
December 31, 2020 1.828B
September 30, 2020 1.485B
June 30, 2020 1.047B
March 31, 2020 1.007B
Date Value
December 31, 2019 1.067B
September 30, 2019 720.59M
June 30, 2019 494.24M
March 31, 2019 497.87M
December 31, 2018 489.02M
September 30, 2018 518.90M
June 30, 2018 353.13M
March 31, 2018 374.45M
December 31, 2017 271.35M
September 30, 2017 282.32M
June 30, 2017 304.98M
March 31, 2017 322.35M
December 31, 2016 344.96M
September 30, 2016 278.65M
June 30, 2016 293.06M
December 31, 2015 159.42M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

494.24M
Minimum
Jun 2019
2.900B
Maximum
Jun 2021
1.921B
Average
2.197B
Median
Jun 2023

Total Assets (Quarterly) Benchmarks

Vertex Pharmaceuticals Inc 22.73B
Intellia Therapeutics Inc 1.301B
Novartis AG 99.94B
Verve Therapeutics Inc 752.69M
AC Immune SA 217.65M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly) 346.77M
Shareholders Equity (Quarterly) 1.883B
Current Ratio 17.54